NFKB1 and acute kidney injury: In a cisplatin-induced AKI mouse model, low-dose cisplatin (RLDC) downregulated SIRT1 and activated NF-κB, triggering chronic renal tubular injury, tubulointerstitial inflammation, and fibrosis.